The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Oxidative Stress and the Use of Antioxidants in Stroke
Open accessAbstract
Transient or permanent interruption of cerebral blood flow by occlusion of a cerebral artery gives rise to an ischaemic stroke leading to irreversible damage or dysfunction to the cells within the affected tissue along with permanent or reversible neurological deficit. Extensive research has identified excitotoxicity, oxidative stress, inflammation and cell death as key contributory pathways underlying lesion progression. The cornerstone of treatment for acute ischaemic stroke remains reperfusion therapy with recombinant tissue plasminogen activator (rt-PA). The downstream sequelae of events resulting from spontaneous or pharmacological reperfusion lead to an imbalance in the production of harmful reactive oxygen species (ROS) over endogenous anti-oxidant protection strategies. As such, anti-oxidant therapy has long been investigated as a means to reduce the extent of injury resulting from ischaemic stroke with varying degrees of success. Here we discuss the production and source of these ROS and the various strategies employed to modulate levels. These strategies broadly attempt to inhibit ROS production or increase scavenging or degradation of ROS. While early clinical studies have failed to translate success from bench to bedside, the combination of anti-oxidants with existing thrombolytics or novel neuroprotectants may represent an avenue worthy of clinical investigation. Clearly, there is a pressing need to identify new therapeutic alternatives for the vast majority of patients who are not eligible to receive rt-PA for this debilitating and devastating disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–206 of 206
David, H., Haelewyn, B., Degoulet, M., Colomb, D. G., Risso, J., & Abraini, J. H. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00092.2012 · Cited by 19
Deguchi, K., Miyazaki, K., Tian, F., Liu, N., Liu, W., Kawai, H., Omote, Y., Kono, S., Yunoki, T., Deguchi, S., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.12.016 · Cited by 18
Neuroprotective effect of adenoviral catalase gene transfer in cortical neuronal cultures
Gáspár, T., Domoki, F., Lenti, L., Institóris, Á., Snipes, J. A., Bari, F., & Busija, D. W. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.006 · Cited by 16
Ducruet, A. F., Mack, W. J., Mocco, J., Hoh, D. J., Coon, A. L., D’Ambrosio, A. L., Winfree, C. J., Pinsky, D. J., & Connolly, E. S. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0084-2 · Cited by 13
Scope of Preclinical Testing Versus Quality Control Within Experiments
O’Collins, V. E., Donnan, G. A., Macleod, M. R., & Howells, D. W. (2009) · Stroke · doi:10.1161/strokeaha.109.550335 · Cited by 12
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Pathophysiology and treatment of stroke: present status and future perspectives
Kuriakose, D., & Xiao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207609 · Cited by 1,350
The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway
Farkhondeh, T., Folgado, S. L., Pourbagher-Shahri, A. M., Ashrafizadeh, M., & Samarghandian, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110234 · Cited by 273
Antioxidants: Positive or Negative Actors?
Salehi, B., Martorell, M., Arbiser, J., Sureda, A., Martins, N., Maurya, P., Sharifi-Rad, M., Kumar, P., & Sharifi-Rad, J. (2018) · Biomolecules · doi:10.3390/biom8040124 · Cited by 255
Deletion of NADPH oxidase 4 reduces severity of traumatic brain injury
Ma, M. W., Wang, J., Dhandapani, K. M., & Brann, D. W. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.031 · Cited by 52
Metadata
- Authors
- Shirley, R., Ord, E., & Work, L.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2014-07-03
- Volume
- 3
- Issue
- 3
- Pages
- 472-501
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W2052239137
- Cited by
- 282
- References
- 206
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.